Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A{sub 2}-mediated progression of acute liver injury

Journal Article · · Toxicology and Applied Pharmacology
;  [1];  [2]
  1. Department of Toxicology, College of Pharmacy, University of Louisiana at Monroe, Monroe, Louisiana (United States)
  2. Toxicologic Pathology Associates, National Centre for Toxicological Research, Jefferson, Arkansas (United States)

Our previous study [Bhave, V. S., Donthamsetty, S., Latendresse, J. R., Muskhelishvili, L., and Mehendale, H. M. 2008-this issue. Secretory phospholipase A{sub 2} mediates progression of acute liver injury in the absence of sufficient COX-2. Toxicol Appl Pharmacol] showed that in the absence of sufficient induction and co-presence of cyclooxygenase-2 (COX-2), secretory phospholipase A{sub 2} (sPLA{sub 2}) appearing in the intercellular spaces for cleanup of post-necrotic debris seems to contribute to the progression of toxicant-initiated liver injury, possibly by hydrolysis of membrane phospholipids of hepatocytes in the perinecrotic areas. To further test our hypothesis on the protective role of COX-2, male Fisher-344 rats were administered a selective COX-2 inhibitor, NS-398, and then challenged with a moderately toxic dose of CCl{sub 4}. This led to a 5-fold increase in the susceptibility of the COX-2 inhibited rats to CCl{sub 4} hepatotoxicity and mortality. The CCl{sub 4} bioactivating enzyme CYP2E1 protein, CYP2E1 enzyme activity, and the {sup 14}CCl{sub 4}-derived radiolabel covalently bound to the liver proteins were unaffected by the COX-2 inhibitor suggesting that the increased hepatotoxic sensitivity of the COX-2 inhibited rats was not due to higher bioactivation of CCl{sub 4}. Further investigation showed that this increased mortality was due to higher plasma and hepatic sPLA{sub 2} activities, inhibited PGE{sub 2} production, and progression of liver injury as compared to the non-intervened rats{sub .} In conclusion, inhibition of COX-2 mitigates the tissue protective mechanisms associated with COX-2 induction, which promotes sPLA{sub 2}-mediated progression of liver injury in an acute liver toxicity model. Because increased sPLA{sub 2} activity in the intercellular space is associated with increased progression of injury, and induced COX-2 is associated with hepatoprotection, ratios of hepatic COX-2 and sPLA{sub 2} activities may turn out to be a useful tool in predicting the extent of hepatotoxicities.

OSTI ID:
21140818
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Journal Issue: 2 Vol. 228; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Secretory phospholipase A{sub 2} mediates progression of acute liver injury in the absence of sufficient cyclooxygenase-2
Journal Article · Tue Apr 15 00:00:00 EDT 2008 · Toxicology and Applied Pharmacology · OSTI ID:21140817

Secretory phospholipase A{sub 2}-mediated progression of hepatotoxicity initiated by acetaminophen is exacerbated in the absence of hepatic COX-2
Journal Article · Tue Mar 15 00:00:00 EDT 2011 · Toxicology and Applied Pharmacology · OSTI ID:21535258

Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity
Journal Article · Tue Mar 14 23:00:00 EST 2006 · Toxicology and Applied Pharmacology · OSTI ID:20783445